Gabelli Funds’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Gabelli Funds’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,055	Closed	-$1.09M	–	1141
2020 Q2	$1.09M	Hold	5,055	–	–	0.01%	788
2020 Q1	$1.06M	Sell	5,055 -855	-14%	-$179K	0.01%	769
2019 Q4	$1.24M	Hold	5,910	–	–	0.01%	819
2019 Q3	$1.22M	Hold	5,910	–	–	0.01%	822
2019 Q2	$1.21M	Hold	5,910	–	–	0.01%	855
2019 Q1	$1.19M	Buy	+5,910	New	+$1.18M	0.01%	844

Other funds holding RVPH

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Gabelli Funds's RVPH Position: Q3 2020 in Review

Gabelli Funds sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2020, closing a stake of 5,055 shares — an estimated $1.09M sold.

Gabelli Funds first reported a position in RVPH in Q1 2019 and held it in 6 quarters. The position peaked at $1.24M in Q4 2019. 13 funds tracked by Wall St. Rank hold RVPH as of Q3 2020.

Gabelli Funds reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2020 after selling out during the quarter.
Gabelli Funds sold 5,055 REVIVA PHARMA HLDGS INC shares in Q3 2020, an estimated $1.09M.
Gabelli Funds first reported a position in REVIVA PHARMA HLDGS INC in Q1 2019 and held it in 6 quarters.
Gabelli Funds's REVIVA PHARMA HLDGS INC position peaked at $1.24M in Q4 2019.
13 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2020.

Based on Gabelli Funds's 13F filing for Q3 2020, filed 6 Nov 2020.